Skip to main content

Leveraging Community-Academic Partnerships to Improve Care for Latinx AYA Cancer Survivors With Stephanie Smith, MD

At the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, Dr. Stephanie Smith, Pediatric Oncologist at Stanford Medicine, sat down with Oncology Data Advisor to discuss her research on leveraging community-academic partnerships to improve access to survivorship care for Latinx adolescent/young adult (AYA) cancer survivors. Dr. Smith explains the barriers faced by this population and the unique role that community cancer centers play in providing equitable care as patients transition into adult survivorship.  

Continue reading

Finding Real-World Response End Points in NSCLC Data Sets With Janet Espirito, PharmD

At the recent American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Janet Espirito, PharmD, a Senior Medical Director at Ontada, sat down with Oncology Data Advisor to discuss her presentation on identifying real-world end points for assessing response in patients receiving novel therapies for metastatic non–small cell lung cancer (NSCLC) outside of clinical trials.  

Continue reading

Understanding Sexual Orientation and Gender Identity Data Collection in Oncology With Mandi Pratt-Chapman, PhD

At the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, Dr. Mandi Pratt-Chapman, Associate Center Director for Community Outreach, Engagement, and Equity at George Washington University Cancer Center, sat down with Oncology Data Advisor to discuss her abstract on difference-making conditions associated with sexual orientation and gender identity (SOGI) data collection among ASCO members' institutions. Dr. Pratt-Chapman gives additional insight into the importance of SOGI data collection for providing patient-centered care and shares advice for instituting data collection processes in order to help guide clinical decision making for LGBTQIA+ patients.  

Continue reading

Metastatic Castration-Sensitive Prostate Cancer: Real-World Characteristics and Treatment by Disease Volume With Stephen Freedland, MD

Oncology Data Advisor® · mCSPC: Real World Characteristics and Treatment by Disease Volume With Stephen Freedland, MD At the recent American Society of Clinical Oncology (ASCO) Annual Meeting, Dr. Stephen Freedland, Professor of Urology at Cedars-Sinai Medical Center, sat down with Oncology Data Advisor to discuss his abstract regarding real-world characteristics and treatment by disease volume among patients with metastatic castration-sensitive prostate cancer. Dr. Freedland shares m...

Continue reading

Expanding Global Health Education Through Video and Social Media With Yan Leyfman, MD

At the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Oncology Data Advisor sat down with Dr. Yan Leyfman, a physician at Mount Sinai Hospital and Director and Host of MedNews Week. Dr. Leyfman explains the origin and reach of MedNews Week and how it strives to combat health care information, champion patient advocacy, and expand global health education through its video and social media platforms.  

Continue reading

Metastatic Castration-Sensitive Prostate Cancer: Real-World Characteristics and Treatment by Disease Volume With Stephen Freedland, MD

At the recent American Society of Clinical Oncology (ASCO) Annual Meeting, Dr. Stephen Freedland, Professor of Urology at Cedars-Sinai Medical Center, sat down with Oncology Data Advisor to discuss his abstract regarding real-world characteristics and treatment by disease volume among patients with metastatic castration-sensitive prostate cancer. Dr. Freedland shares more regarding the complexities of treatment decisions in prostate cancer, barriers to care, and the research that he and his team are conducting to optimize treatment utilization based on disease characteristics.  

Continue reading

Partnering With Patients: A Collection of Perspectives From ASCO 2023

Oncology Data Advisor holds the utmost value for patient advocates and advocacy groups as they strive to prioritize patient-centered care and shared decision making throughout the cancer journey. At this year's American Society of Clinical Oncology (ASCO) Annual Meeting, Oncology Data Advisor spoke with numerous individuals representing diverse aspects of oncology and asked them how they strive to partner with patients in their practice, research, and advocacy work.   Allison Rosen, Patient...

Continue reading

Groundbreaking Results of Mirvetuximab Soravtansine for Ovarian Cancer With Kathleen Moore, MD

Oncology Data Advisor® · Groundbreaking Results of Mirvetuximab Soravtansine for Ovarian Cancer With Kathleen Moore, MD Welcome to Oncology Data Advisor, a digital resource for the multidisciplinary cancer team. At the recent American Society of Clinical Oncology (ASCO) Annual Meeting, Kathleen Moore, MD, Associate Director of Clinical Research and Professor of Gynecologic Oncology at the Stephenson Cancer Center at the University of Oklahoma, sat down to discuss in detail her present...

Continue reading

Final Overall Survival Results of the CLEAR Study in Renal Cell Carcinoma With Thomas Hutson, MD

Oncology Data Advisor® · Final Overall Survival Results of the CLEAR Study in Renal Cell Carcinoma With Thomas Hutson, MD At the recent American Society of Clinical Oncology (ASCO) Annual Meeting, Dr. Thomas Hutson, Director of the Urologic Oncology Cancer Research and Treatment Center at Baylor Sammons Cancer Center, discusses the results of the CLEAR study, in which he and his co-investigators measured the safety and efficacy of lenvatinib plus pembrolizumab for treatment of advance...

Continue reading

Empowering Young Adult Cancer Survivors Through Adventure: Project Koru With Beth Peck

Project Koru is a nonprofit organization that seeks to enrich the lives of young adult cancer survivors through outdoor and adventure-based community experiences. At the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Beth Peck, the organization's Executive Director, sat down with Oncology Data Advisor to talk about its mission and the excitement of sharing the ASCO experience with others who have a common goal.

This podcast episode was recorded live at the 2022 ASCO Annual Meeting in Chicago by Oncology Data Advisor and ConveyMed. 

Continue reading

Supporting Patients Through Employment Disruptions During Cancer With Michael Halpern, MD, PhD, MPH

In this interview from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, Dr. Michael Halpern, Medical Officer in the National Cancer Institute's Healthcare Delivery Research Program, discusses his team's study investigating the effects of employment disruptions on financial hardship experienced by patients with cancer. Dr. Halpern shares advice for how employers can provide support and accommodation in the workplace for their employees during cancer treatment, as well as advice for clinicians on how to partner with patients to address financial hardships.  

Continue reading

Sharing the Breast Cancer Journey From Diagnosis to Survivorship With Megan-Claire Chase

At the recent American Society of Clinical Oncology (ASCO) Annual Meeting, Megan-Claire Chase, breast cancer survivor and Breast Cancer Program Director at SHARE Cancer Support, sat down with Oncology Data Advisor to talk about her diagnosis, treatment, and survivorship journey, as well as her advocacy work to empower people living with cancer.

This podcast episode was recorded live at the 2022 ASCO Annual Meeting in Chicago by Oncology Data Advisor and ConveyMed. 

Continue reading

Coping With the Uncertainty of Indolent Non-Hodgkin Lymphoma With Richard Newcomb, MD

At the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, Dr. Richard Newcomb, Hematology/Oncology Fellow at Dana-Farber/Mass General Cancer Center, sat down with Oncology Data Advisor to elaborate on his study regarding uncertainty and coping experienced by patients with newly diagnosed indolent non-Hodgkin lymphoma (NHL), as well as strategies for supporting patients facing distress around their diagnosis.  

Continue reading

Payment Reform Through the Enhancing Oncology Model With Lalan Wilfong, MD

Oncology Data Advisor® · Payment Reform Through the Enhancing Oncology Model With Lalan Wilfong, MD At the recent American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Oncology Data Advisor sat down for a conversation with Dr. Lalan Wilfong, the Senior Vice President of Payer and Care Transformation for the US Oncology Network, to discuss his presentation concerning payment reform and lessons learned from the Oncology Care Model (OCM) and the Enhancing Oncology Model...

Continue reading

Improving Access to Hereditary Cancer Genetic Testing for Black Individuals and Their Families With Darya Kizub, MD

At the recent 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, Dr. Darya Kizub, Hematology-Oncology Fellow at MD Anderson Cancer Center, presented her team's research regarding a novel initiative for recruiting Black individuals to be screened for hereditary cancer genetic testing eligibility. Prior to presenting, she sat down with Oncology Data Advisor to share more about the need to provide cancer genetic testing for Black individuals and the ways that she and her team have partnered with the community to enact this change.  

Continue reading

Exciting New Directions for Oncology Data Advisor: Live From ASCO 2023 With Dr. Thomas Abrams, Editor in Chief

Oncology Data Advisor® · Exciting New Directions for Oncology Data Advisor: Live From ASCO 2023 With Dr.Thomas Abrams At the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Dr. Thomas Abrams, Editor in Chief of Oncology Data Advisor, previewed some of the latest updates on Oncology Data Advisor and the new directions that will be taken in 2023, including new ways of partnering with patients to strengthen the patient voice and ultimately improve quality of ...

Continue reading

Social Media’s Effect on Informed Decision Making in Cancer Treatment With Nina Morena, MA, and Ari Meguerditchian, MD

Oncology Data Advisor® · Social Media’s Effect on Informed Decision Making in Cancer Treatment Welcome to Oncology Data Advisor®, a digital resource for the multidisciplinary cancer team. In this podcast episode, Nina Morena, MA, PhD Candidate at McGill University, and Ari Meguerditchian, MD, Surgical Oncologist at McGill University Health Center, sit down to talk about Ms. Morena's thesis topic and research, How reliable are post-mastectomy breast reconstruction videos on YouTu...

Continue reading

Trastuzumab Deruxtecan Safety in HER2-Expressing Solid Tumors With Funda Meric-Bernstam, MD

Oncology Data Advisor® · Trastuzumab Deruxtecan Safety on HER2 Expressing Solid Tumors With Funda Meric-Bernstam, MD At the recent 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, Dr. Funda Meric-Bernstam, the Department Chair in the Department of Vascular Cancer Therapeutics at MD Anderson Cancer Center, sat down with Oncology Data Advisor to discuss her presentation of the results of the Destiny-PanTumor-02 trial, in which her team studied the safety of trastuzumab ...

Continue reading

An Exclusive Playlist From the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting

At the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Oncology Data Advisor® had the privilege of interviewing many distinguished physician, nurse, pharmacist, pathologist, and patient advocate speakers about their work and research. This playlist features video and podcast conversations on topics including shared decision making in renal cell carcinoma, nursing research regarding digital health for cancer survivors, social determinants of health in genetic testing for triple-negative breast cancer, an exclusive conversation with OncData's Editor in Chief, Dr. Thomas Abrams, and much more! 

Continue reading

Exciting New Directions for Oncology Data Advisor: Live From ASCO 2023 With Dr. Thomas Abrams, Editor in Chief

At the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Dr. Thomas Abrams, Editor in Chief of Oncology Data Advisor, previewed some of the latest updates on Oncology Data Advisor and the new directions that will be taken in 2023, including new ways of partnering with patients to strengthen the patient voice and ultimately improve quality of care.  

Continue reading